石药集团(01093.HK)新药SYH2046片获美FDA批准开展临床试验

阿斯达克财经
Yesterday

石药集团(01093.HK) 公布,集团开发的化药1类新药SYH2046片获美国食品药品监督管理局(FDA)批准,可以在美国开展临床试验,本次获批的临床试验适应症为急性心肌梗死后心力衰竭。该产品已于今年4月获中国国家药品监督管理局批准展临床试验。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-05-09 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10